Press coverage about Ceres (NASDAQ:CERE) has been trending somewhat positive recently, Accern reports. The research firm rates the sentiment of media coverage by analyzing more than 20 million blog and news sources. Accern ranks coverage of publicly-traded companies on a scale of negative one to one, with scores closest to one being the most favorable. Ceres earned a media sentiment score of 0.07 on Accern’s scale. Accern also gave news coverage about the biotechnology company an impact score of 44.6014732704062 out of 100, meaning that recent media coverage is somewhat unlikely to have an effect on the stock’s share price in the near term.

Here are some of the news articles that may have effected Accern Sentiment Analysis’s rankings:

TRADEMARK VIOLATION WARNING: “Somewhat Positive Press Coverage Somewhat Unlikely to Impact Ceres (CERE) Stock Price” was posted by Daily Political and is the property of of Daily Political. If you are accessing this piece of content on another domain, it was illegally stolen and reposted in violation of international copyright legislation. The correct version of this piece of content can be viewed at https://www.dailypolitical.com/2017/09/09/somewhat-positive-press-coverage-somewhat-unlikely-to-impact-ceres-cere-stock-price.html.

About Ceres

Ceres, Inc is an agricultural biotechnology company that develops and markets seeds and traits to produce crops for feed, forages, sugar and other markets. The Company uses a combination of plant breeding, biotechnology and bioinformatics to develop seed products and biotechnology traits. Its Forage sorghum seeds are used for growing feed for livestock, including dairy and beef cattle.

Insider Buying and Selling by Quarter for Ceres (NASDAQ:CERE)

Receive News & Ratings for Ceres Inc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Ceres Inc and related companies with MarketBeat.com's FREE daily email newsletter.